Mechanisms of sepsis-induced organ dysfunction

Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
Critical Care Medicine (Impact Factor: 6.15). 10/2007; 35(10):2408-16. DOI: 10.1097/01.CCM.0000282072.56245.91
Source: PubMed

ABSTRACT The past several years have seen remarkable advances in understanding the basic cellular and physiologic mechanisms underlying organ dysfunction and recovery relating to sepsis. Although several new therapeutic approaches have improved outcome in septic patients, the far-reaching potential of these new insights into sepsis-associated mechanisms is only beginning to be realized.
The Brussels Round Table Conference in 2006 convened >30 experts in the field of inflammation and sepsis to review recent advances involving sepsis and to discuss directions that the field is likely to take in the near future.
Current understanding of the pathophysiology underlying sepsis-induced multiple organ dysfunction highlights the multiple cell populations and cell-signaling pathways involved in this complex condition. There is an increasing appreciation of interactions existing between different cells and organs affected by the septic process. The intricate cross-talk provided by temporal changes in mediators, hormones, metabolites, neural signaling, alterations in oxygen delivery and utilization, and by modifications in cell phenotypes underlines the adaptive and even coordinated processes beyond the dysregulated chaos in which sepsis was once perceived. Many pathologic processes previously considered to be detrimental are now viewed as potentially protective. Applying systems approaches to these complex processes will permit better appreciation of the effectiveness or harm of treatments, both present and future, and also will allow development not only of better directed, but also of more appropriately timed, strategies to improve outcomes from this still highly lethal condition.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nuclear factor (NF)-κB plays a pivotal role in sepsis. Activation of NF-κB is initiated by the signal-induced ubiquitination and subsequent degradation of inhibitors of kappa B (IκBs) primarily via activation of the IκB kinase (IKK). This study was designed to investigate the effects of IKK inhibition on sepsis-associated multiple organ dysfunction/injury (MOD) and to elucidate underlying signaling mechanisms in two different in vivo models: Male C57BL/6 mice were subjected to either bacterial cell wall components [lipopolysaccharide (LPS)/peptidoglycan (PepG)] or underwent cecal ligation and puncture (CLP) to induce sepsis-associated MOD. One hour after LPS/PepG or CLP mice were treated with the IKK inhibitor IKK 16 (1 mg/kg). At 24 hours parameters of organ dysfunction/injury were assessed in both models. Mice developed a significant impairment in systolic contractility (echocardiography), a significant increase in serum creatinine, alanine aminotransferase as well as lung myeloperoxidase activity, and, thus, cardiac dysfunction, renal dysfunction and hepatocellular injury as well as lung inflammation, respectively. Treatment with IKK 16 attenuated the impairment in systolic contractility, renal dysfunction, hepatocellular injury and lung inflammation in LPS/PepG induced multiple organ dysfunction/injury and in polymicrobial sepsis. Compared with mice that were injected with LPS/PepG or underwent CLP, immunoblot analyzes of heart and liver tissues from mice that were injected with LPS/PepG or underwent CLP and treated with IKK 16 revealed a significant attenuation of the i) increased phosphorylation of IκBα; ii) increased nuclear translocation of the NF-κB subunit p65; iii) significant increase in inducible nitric oxide synthase (iNOS) expression; and iv) revealed a significant increase in the phosphorylation of Akt and endothelial nitric oxide synthase (eNOS). Here, we report for the first time that delayed IKK inhibition reduces MOD in experimental sepsis. We suggest that this protective effect is (at least in part) attributable to inhibition of inflammation through NF-κB, the subsequent decreased iNOS expression and the activation of the Akt/eNOS survival pathway.
    Disease Models and Mechanisms 05/2013; DOI:10.1242/dmm.012435 · 5.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Immunoinflammatory response in critically ill patients is very complex. This review explores some of the new elements of immunoinflammatory response in severe sepsis, tumor necrosis factor-alpha in severe acute pancreatitis as a clinical example of immune response in sepsis, immune response in severe trauma with or without secondary sepsis, and genetic aspects of host immuno-inflammatory response to various insults in critically ill patients.
    Mediators of Inflammation 01/2013; 2013:362793. DOI:10.1155/2013/362793 · 2.42 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Critically ill patients suffer a high rate of nosocomial infection with secondary sepsis being a common cause of death. Usage of antibiotics and catecholamines is often necessary, but it can compromise complex immune response to infection. This review explores influence of these life-saving drugs on host immune response to severe infection.
    The Scientific World Journal 01/2013; 2013:961852. DOI:10.1155/2013/961852 · 1.73 Impact Factor


Available from